| Ytd | -66.55% | |
| 1y | -77.57% |
| Open | 0.93 | Prev Close | 0.96 | Low | 0.93 | High | 0.99 | Mkt Cap | 102.47M |
| Vol | 2.57M | Avg Vol | 548.23K | EPS | -1.62 | P/E | N/A | Forward P/E | 13.42 |
| Beta | 1.33 | Short Ratio | 4.71 | Inst. Own | 95.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 0.80 | 200-d Avg | 1.31 | 1yr Est | 5.25 |
DH News
HealthStream (NASDAQ: HSTM - Get Free Report) and Definitive Healthcare (NASDAQ: DH - Get Free Repor
Gainers bioAffinity Technologies (NASDAQ:BIAF) stock moved upwards by 54.3% to $10.17 during Wednes
FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”
Definitive Healthcare Corp. ("Definitive Healthcare") (Nasdaq: DH), an industry leader in he
FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healt
Definitive Healthcare (NASDAQ: DH - Get Free Report) and Certara (NASDAQ: CERT - Get Free Report) ar
Definitive Healthcare Corp. (NASDAQ: DH - Get Free Report) has received a consensus rating of "Reduc
Morgan Stanley analyst Craig Hettenbach maintains Definitive Healthcare (NASDAQ:DH) with a Equal-
Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.05 per share, beating the Za
Definitive Healthcare NASDAQ: DH reported second-quarter fiscal 2026 revenue and profitability that
Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's af
Definitive Healthcare (NASDAQ:DH) raises FY2026 Adj EPS guidance from $0.16-$0.19 to $0.18-$0.20 vs
Definitive Healthcare (NASDAQ:DH) is looking for Q3 Adj EPS of $0.04-$0.05 vs $0.04 analyst estimate
Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.05 per share which beat the anal
Unifying claims, provider, consumer, and expert data enables organizations to uncover growth opportu
FRAMINGHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Health
Definitive Healthcare (DH) doesn't possess the right combination of the two key ingredients for a li
FRAMINGHAM, Mass., July 27, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry
B of A Securities analyst Allen Lutz downgrades Definitive Healthcare (NASDAQ:DH) from Buy to Und
Customer success leader joins executive team to help restaurant operators accelerate value realizati
FRAMINGHAM, Mass. , May 21, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), a provider
Definitive Healthcare Corp. (DH) Q1 2026 Earnings Call Transcript
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.06 per share, beating the Za
FRAMINGHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthc
Definitive Healthcare (DH) doesn't possess the right combination of the two key ingredients for a li
FRAMINGHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healt
Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and l
Health care sector has oversold stocks, RSI momentum indicator can help traders predict short term p
Canaccord Genuity analyst David Hynes maintains Definitive Healthcare (NASDAQ:DH) with a Hold and
Stephens & Co. analyst Jeff Garro maintains Definitive Healthcare (NASDAQ:DH) with a Equal-We
Definitive Healthcare (NASDAQ:DH) is looking for FY2026 Adj EPS of $0.14-$0.17 vs $0.26 analyst esti
Definitive Healthcare (NASDAQ:DH) is looking for Q1 Adj EPS of $0.03 vs $0.06 analyst estimate. sees
Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.06 per share which met the analy
Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and l
